Combined markers for metastatic cancer and uses thereof
US12174190B2 · kind B2 · utility
0Cited by
0References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 2018 |
| Grant date | Dec 24, 2024 |
| Priority date | — |
| Expiry date | Dec 15, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H30/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A combination of markers (TMEM, MenaCalc, and MenalNV) for hematogenous metastatic cancer and their use for diagnosis, prognosis and predictive performance are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.